Share this page

Latest news

Article

VIDEO: Urgent political support needed to protect the Sahel's 25 million children (Politics Home)

16 September 2015

This article was originally published on Politics Home.

The organisation calls for urgent political and financial support of seasonal malaria chemoprevention to protect children from malaria 'when they are most at risk.'

The majority of malaria related deaths worldwide occur in Sub-Saharan Africa, with children under five at greatest risk.

For the 25 million children living across the Sahel, where there is a seasonal surge in malaria incidence, the World Health Organization recommends seasonal malaria chemoprevention (SMC) as an effective tool to prevent malaria.

Malaria Consortium was the to first to trial a seasonal malaria chemoprevention (SMC) intervention in 2013, rolling out a pilot project in Katsina state, Nigeria. Following encouraging results, Malaria Consortium and partners were awarded a UNITAID grant to collaborate with National Malaria Control programmes to lead the first-ever at-scale roll out of seasonal malaria chemoprevention (SMC) across seven countries in the Sahel region: Burkina Faso, Chad, Guinea Conakry, Mali, Niger, Nigeria and The Gambia. Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) will provide 45 million preventive treatments over the next two years, helping to protect over 10 million children from malaria.

Country: The Gambia | Mali | Burkina Faso | Chad | Nigeria | Niger

Keywords: Advocacy and policy

Related projects

ACCESS-SMC  

 

Related content

16 September 2013

Seasonal Malaria Chemoprevention: leading the way on an innovative approach in Nigeria

Type: News article
30 November 2015

SMC in the Sahel: Protecting Northern Nigeria's most vulnerable population

Type: News article
25 April 2016

ACCESS-SMC through the lens

Type: News article
4 July 2016

Video series on Malaria Consortium-led project in the Sahel

Type: News article

 

Click here for news archive »